Live Breaking News & Updates on Pier Vincenzo Piazza

Stay updated with breaking news from Pier vincenzo piazza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of First Drug Candidate for Cannabis Use Disorder

Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of First Drug Candidate for Cannabis Use Disorder
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Frances Levin , Daelis Farma , Neurocentre Magendie , Margaret Meg Haney , Arthur Rouill , Vincenzo Piazza , Dusan Oresansky , Charlotte Wray , Mental Health Service , University Of Bordeaux , Cannabis Research Laboratory , American Psychiatric Association , National Survey On Drug , National Institute Of Drug Abuse , Substance Use Research Center , Lancet Regional Health , Columbia University , Columbia University Irving Medical Center , French National Institute Of Health , French National Institute , Medical Research , Substance Use Research , National Institute , Drug Abuse , University Irving Medical Center ,

Nature Medicine Publishes Discovery of New Pharmacological Class by Aelis Farma, Phase 2a Study of F

Cannabis use disorder (CUD) affects over 14 million individuals in the USDespite the urgent need, there are no FDA-approved medications to treat CUD; behavioral treatments have shown limited benefitAEF0117 is the first of a new pharmacologic class, type 1 cannabinoid receptor signaling-specific inhibitors (CB1-SSi),. ....

United States , Margaret Meg Haney , Arthur Rouill , Neurocentre Magendie , Vincenzo Piazza , Frances Levin , Daelis Farma , Charlotte Wray , Dusan Oresansky , Mental Health Service , French National Institute Of Health , Cannabis Research Laboratory , American Psychiatric Association , Substance Use Research Center , Columbia University , University Of Bordeaux , Lancet Regional Health , Columbia University Irving Medical Center , National Institute Of Drug Abuse , National Survey On Drug , Regulatory News , French National Institute , Medical Research , Substance Use Research , National Institute , Drug Abuse ,

Results of Aelis Farma Combined General Meeting of May 24, 2023

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces that all the ....

United States , Gewinn Nur , Arthur Rouill , Daelis Farma , Vincenzo Piazza , Magendie Neurocenter , Anders Gersel Pedersen , Regulatory News , Combined General Meeting , Chief Executive Officer , Lafaurie De Monbadon , Signaling Specific , Pier Vincenzo Piazza , Down Syndrome , Euronext Paris , Universal Registration Document , Des March ,

Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs ....

United States , France General , Vincenzo Piazza , Magendie Neurocenter , Daelis Farma , Arthur Rouill , Combined General Meeting , Lafaurie De Mondabon , General Meeting , Investors General , Commercial Code , Signaling Specific , Pier Vincenzo Piazza , Down Syndrome , Euronext Paris , Universal Registration Document , Des March ,

Aelis Farma: Publication of the 2022 Universal Registration Document

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces ....

France General , United States , Daelis Farma , Arthur Rouill , Vincenzo Piazza , Magendie Neurocenter , French Financial Markets Authority Autorit , Regulatory News , Registration Document , French Financial Markets Authority , Des March , Universal Registration Document , Investors Documentation , General Meeting , Signaling Specific , Pier Vincenzo Piazza , Down Syndrome , Euronext Paris ,